ES502498A0 - Procedimiento para preparar un complejo de coagulacion san- guinea - Google Patents

Procedimiento para preparar un complejo de coagulacion san- guinea

Info

Publication number
ES502498A0
ES502498A0 ES502498A ES502498A ES502498A0 ES 502498 A0 ES502498 A0 ES 502498A0 ES 502498 A ES502498 A ES 502498A ES 502498 A ES502498 A ES 502498A ES 502498 A0 ES502498 A0 ES 502498A0
Authority
ES
Spain
Prior art keywords
factor
activity
vii
coagulation factors
guinea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES502498A
Other languages
English (en)
Other versions
ES8300017A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22547053&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES502498(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of ES502498A0 publication Critical patent/ES502498A0/es
Publication of ES8300017A1 publication Critical patent/ES8300017A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/647Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017Filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022Filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES502498A 1980-05-27 1981-05-26 Procedimiento para preparar un complejo de coagulacion san- guinea Expired ES8300017A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15339680A 1980-05-27 1980-05-27

Publications (2)

Publication Number Publication Date
ES502498A0 true ES502498A0 (es) 1982-10-01
ES8300017A1 ES8300017A1 (es) 1982-10-01

Family

ID=22547053

Family Applications (2)

Application Number Title Priority Date Filing Date
ES502498A Expired ES8300017A1 (es) 1980-05-27 1981-05-26 Procedimiento para preparar un complejo de coagulacion san- guinea
ES513171A Granted ES513171A0 (es) 1980-05-27 1982-06-16 Procedimiento de obtencion de una composicion estable liofilizada para el control del sangrado en hemofilias.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES513171A Granted ES513171A0 (es) 1980-05-27 1982-06-16 Procedimiento de obtencion de una composicion estable liofilizada para el control del sangrado en hemofilias.

Country Status (6)

Country Link
EP (1) EP0041174B1 (es)
JP (1) JPS5711924A (es)
AT (1) ATE15489T1 (es)
CA (1) CA1170183A (es)
DE (1) DE3172210D1 (es)
ES (2) ES8300017A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
FR2622108B1 (fr) * 1987-10-23 1990-03-02 Lille Transfusion Sanguine Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
DE3826792C1 (es) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3914869C1 (es) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De
DE59712322D1 (de) * 1996-03-20 2005-06-30 Baxter Ag Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen

Also Published As

Publication number Publication date
ES8304799A1 (es) 1983-03-16
CA1170183A (en) 1984-07-03
JPS5711924A (en) 1982-01-21
ATE15489T1 (de) 1985-09-15
EP0041174B1 (en) 1985-09-11
ES513171A0 (es) 1983-03-16
ES8300017A1 (es) 1982-10-01
EP0041174A1 (en) 1981-12-09
DE3172210D1 (en) 1985-10-17

Similar Documents

Publication Publication Date Title
AT398079B (de) Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
Marciniak Factor‐Xa Inactivation by Antithrombin III: Evidence for Biological Stabilization of Factor Xa by Factor V–Phospholipid Complex
DE3843126C3 (de) Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5151355A (en) Process for the production of high purity thrombin
EP0230945A3 (en) Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same
DE3473407D1 (en) Method of inactivating pathogens
JPH0150208B2 (es)
DE3165965D1 (en) Blood-coagulation-promoting products and methods of preparing them
ATE179425T1 (de) Verfahren zur abreicherung oder entfernung von endotoxinen
AU7264287A (en) A process for the preparation of a factor V concentrate
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
ES502498A0 (es) Procedimiento para preparar un complejo de coagulacion san- guinea
US4510084A (en) Method of producing an antithrombin III-heparin concentrate or antithrombin III-heparinoid concentrate
EP0356836A3 (en) Thrombin-binding substance and process for preparing the same
MX167398B (es) Procedimiento para pasterizar plasma o concentrados de factores, ii, vii, ix y x de coagulacion de sangre
DE3060262D1 (en) Control reagent for the determination of the activity of heparin
KR930009612A (ko) 바이러스-유리된 트롬빈 농축물 제조방법
JPS646292A (en) Manufacture of active-form protein
DE69433875D1 (de) Verfahren zur präparation von humanem aktiviertem protein c
KR920700220A (ko) 활성 단백질c의 제조방법과 이러한 방법으로 제조된 활성 단백질c
DE3586197D1 (de) Verfahren zur reinigung sowie pasteurisierung von urokinase.
Jacobs et al. Contact activation of factor XI
JPS6351336A (ja) プロトロンビン含量の低いビタミンk依存性凝固因子製剤の製法